Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer

NCT00153907 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Navelbine
DRUG: Capecitabine

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]